HealthInvest Partners AB as of March 31, 2016
Portfolio Holdings for HealthInvest Partners AB
HealthInvest Partners AB holds 18 positions in its portfolio as reported in the March 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Anika Therapeutics (ANIK) | 10.3 | $22M | 490k | 44.72 | |
FEI Company | 10.0 | $21M | 240k | 89.01 | |
LifePoint Hospitals | 8.9 | $19M | 274k | 69.25 | |
Gnc Holdings Inc Cl A | 8.7 | $19M | 587k | 31.75 | |
AMAG Pharmaceuticals | 8.1 | $17M | 741k | 23.40 | |
Supernus Pharmaceuticals (SUPN) | 6.5 | $14M | 904k | 15.25 | |
Charles River Laboratories (CRL) | 6.3 | $14M | 178k | 75.94 | |
Taro Pharmaceutical Industries (TARO) | 6.3 | $14M | 94k | 143.25 | |
Inc Resh Hldgs Inc cl a | 6.3 | $13M | 324k | 41.21 | |
Merck & Co (MRK) | 6.2 | $13M | 251k | 52.91 | |
Anthem (ELV) | 6.1 | $13M | 94k | 138.99 | |
Triple-S Management | 5.9 | $13M | 504k | 24.86 | |
Valeant Pharmaceuticals Int | 4.6 | $9.7M | 370k | 26.30 | |
Symmetry Surgical | 1.5 | $3.1M | 316k | 9.86 | |
OraSure Technologies (OSUR) | 1.4 | $2.9M | 406k | 7.23 | |
DepoMed | 1.3 | $2.8M | 200k | 13.93 | |
SciClone Pharmaceuticals | 1.2 | $2.6M | 236k | 11.00 | |
ImmuCell Corporation (ICCC) | 0.5 | $1.2M | 168k | 6.85 |